Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 240 participants.
Also called NCT03592823
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 240 participants
- Registry
-
NCT03592823
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT03592823. Randomized; double masking; primary purpose prevention. Start 2018-08-01 (anticipated); primary completion 2019-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Hydroxychloroquine Sulfate 200 Mg Tablet
- Lead sponsor
- First Affiliated Hospital of Harbin Medical University
Record details
- Record id
cardio:ct-nct03592823- Content hash
f7342b1399810d48025f72e384af5199c3c1e304d517e9c8f0fc8d5f661f709e